Laurence Skillern

585 citations

19 papers · 424 indexed · h-index 10

Impact in

Obstetrics and Gynecology top 2%
- Pregnancy and preeclampsia studies
Reproductive Medicine top 10%

Papers in

Obstetrics and Gynecology 6
- Pregnancy and preeclampsia studies 5
Reproductive Medicine 6
- Hypothalamic control of reproductive hormones 3
- Endometriosis Research and Treatment 3

Co-authors: Philip N. Baker Alison McLeod Gary Mires Andrew Shennan David Howe Graeme L. Fraser Steven Ramael Samuel Lederman
Journals: Hypertension in Pregnancy (3 papers)Menopause The Journal of The North American Menopause Society (2 papers)Annals of the Rheumatic Diseases (2 papers)Acta Obstetricia Et Gynecologica Scandinavica (2 papers)Human Reproduction (1 paper)
Partner nations: United Kingdom United States Netherlands

In The Last Decade

Laurence Skillern

18 papers receiving 419 citations

Peers

Countries citing papers authored by Laurence Skillern

Since Specialization

Citations

This map shows the geographic impact of Laurence Skillern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurence Skillern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurence Skillern more than expected).

Fields of papers citing papers by Laurence Skillern

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurence Skillern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurence Skillern. The network helps show where Laurence Skillern may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Laurence Skillern, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Laurence Skillern Line = papers co-authored together Laurence Skillern links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work
1	A phase 2b, randomized, placebo-controlled, double-blind, dose-ranging study of the neurokinin 3 receptor antagonist fezolinetant for vasomotor symptoms associated with menopause Menopause The Journal of The North American Menopause Society ·Graeme L. Fraser, Samuel Lederman, Arthur Waldbaum, Robin Kroll, Nanette Santoro, Misun Lee, Laurence Skillern, Steven Ramael	2020	75
2	OP0234 MBS2320, A NOVEL SELECTIVE MODULATOR OF IMMUNE METABOLISM, IN PATIENTS WITH SEVERE RHEUMATOID ARTHRITIS: SAFETY, TOLERABILITY AND EFFICACY RESULTS OF A PHASE 2 STUDY Annals of the Rheumatic Diseases ·Lisa Patel, Laurence Skillern, Robert S Ennis, Andrew Gray, Robert D. Leff, Dina Sagita	2020	1
3	Effect of the neurokinin 3 receptor antagonist fezolinetant on patient-reported outcomes in postmenopausal women with vasomotor symptoms: results of a randomized, placebo-controlled, double-blind, dose-ranging study (VESTA) Menopause The Journal of The North American Menopause Society ·Nanette Santoro, Arthur Waldbaum, Samuel Lederman, Robin Kroll, Graeme L. Fraser, Christopher Lademacher, Laurence Skillern, James Young, Steven Ramael	2020	44
4	OR33-6 The Neurokinin 3 Receptor Antagonist, Fezolinetant, Is Effective in Treatment of Menopausal Vasomotor Symptoms: A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging Study Journal of the Endocrine Society ·Graeme L. Fraser, Samuel Lederman, Arthur Waldbaum, Misun Lee, Laurence Skillern, Steven Ramael	2019	3
5	Efficacy and safety of ASP1707 for endometriosis-associated pelvic pain: the phase II randomized controlled TERRA study Human Reproduction ·Thomas D’Hooghe, Takao Fukaya, Yutaka Osuga, R. Besuyen, M. Steinhäußer, Gertjan M. Holtkamp, Doğrudan Ve, Laurence Skillern	2019	12
6	The neurokinin 3 receptor antagonist, fezolinetant, is effective in treatment of menopausal vasomotor symptoms: a randomized, placebo-controlled, double-blind, dose-ranging study Maturitas ·Graeme L. Fraser, Samuel Lederman, Arthur Waldbaum, Misun Lee, Laurence Skillern, Steven Ramael	2019	2
7	THU0186 SAFETY, TOLERABILITY AND PHARMACOKINETICS OF MBS2320, A SELECTIVE MODULATOR OF IMMUNE METABOLISM, IN HEALTHY VOLUNTEERS AND PATIENTS WITH RHEUMATOID ARTHRITIS Annals of the Rheumatic Diseases ·Lisa Patel, م. د. عادل صبحي عبد القادر الباشا, Jim Bush, Andy Gray, Richard J. Fitzgerald, Sonya Abraham, Marianne Grymer Bargeman, Hiep Huatan, Laurence Skillern, Anna Daroszewska, Rob vanʼt Hof, Sam Williams	2019	0
8	Is drug-induced bone loss acceptable in premenopausal women? A practical fracture risk modeling exercise Osteoporosis International ·Neil Binkley, R. Besuyen, Thomas Fuerst, Laurence Skillern, Didier Hans	2017	7
9	Sildenafil for the Treatment of Preeclampsia Hypertension in Pregnancy ·Jens Niehaus, Gary Mires, Andrew Shennan, Laurence Skillern, David Howe, Alison McLeod, Philip N. Baker	2010	1
10	Phosphodiesterase Inhibitor Effect on Small Artery Function in Preeclampsia Hypertension in Pregnancy ·Jens Niehaus, Mark Wareing, Laurence Skillern, Philip N. Baker	2010	15
11	Effect of Food on the Pharmacokinetics and Pharmacodynamics of an Oral Ghrelin Agonist (ARD‐07) in Healthy Subjects The Journal of Clinical Pharmacology ·Han-Ki Son, G.-A. Chaudron, Yo'ldoshev Sharofiddin Faxriddin o'g'li, Gregory Earl Sell, Finn Ole Larsen, Laurence Skillern, Jürgen Drewe, Christoph Beglinger	2009	8
12	A Randomised, Double-Blinded, Placebo-Controlled Study of the Phosphodiesterase Type 5 Inhibitor Sildenafil for the Treatment of Preeclampsia Hypertension in Pregnancy ·Jens Niehaus, Gary Mires, Andrew Shennan, Laurence Skillern, David Howe, Alison McLeod, Philip N. Baker	2009	125
13	EFFICACY AND SAFETY OF TEVERELIX LA, A NEW GNRH ANTAGONIST IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA (BPH). RESULTS FROM A PHASE II RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTRE, MULTINATIONAL STUDY INVESTIGATING TWO SINGLE INJECTIONS OF 30 MG OR 60 MG (SEPARATED BY AT LEAST 12 WEEKS) ADMINISTERED SC TO TREATMENT NAIVE PATIENTS SUFFERING FROM BPH European Urology Supplements ·Han-Ki Son, Laurence Skillern, В.В. Коненко, 透小原, 水野靖弘, EM Bakeman, Daniel Eduardo Restrepo Sánchez, Ojasvi Rajeev Sharma	2008	2
14	Intrauterine pressure, ischemia markers, and experienced pain during administration of a vasopressin V_1a receptor antagonist in spontaneous and vasopressin‐induced dysmenorrhea Acta Obstetricia Et Gynecologica Scandinavica ·María Lorenzo Morote, Yu. M. Khachatryan, A Mohammed Rehab, Ian James, Alison McLeod, Laurence Skillern, Mats Åkerlund	2006	16
15	Validation of a test model of induced dysmenorrhea Acta Obstetricia Et Gynecologica Scandinavica ·María Lorenzo Morote, Laurence Skillern, Ian James, Alison McLeod, Yu. M. Khachatryan, Mats Åkerlund	2006	12
16	Effects of a phosphodiesterase-5 (PDE5) inhibitor on endothelium-dependent relaxation of myometrial small arteries American Journal of Obstetrics and Gynecology ·Mark Wareing, Jenny Myers, Maureen O’Hara, Louise C. Kenny, Averil Y. Warren, Michael J. Taggart, Laurence Skillern, Machin Ian, Philip N. Baker	2004	53
17	Phosphodiesterase-5 inhibitors and omental and placental small artery function in normal pregnancy and pre-eclampsia European Journal of Obstetrics & Gynecology and Reproductive Biology ·Mark Wareing, Jenny Myers, Maureen O’Hara, Louise C. Kenny, Michael J. Taggart, Laurence Skillern, Machin Ian, Philip N. Baker	2004	30
18	An audit of general practitioner requests for pelvic ultrasound: analysis of referral patterns and outcome BJOG An International Journal of Obstetrics & Gynaecology ·Laurence Skillern, J. Malcolm Pearce	1993	5
19	Coping with extraperitoneal insufflation during laparoscopy: a new technique. PubMed ·和雄増田, Laurence Skillern	1992	13

About Laurence Skillern

Laurence Skillern is a scholar working on Obstetrics and Gynecology, Reproductive Medicine, Endocrinology, Diabetes and Metabolism, Psychiatry and Mental health and Critical Care and Intensive Care Medicine, having authored 19 papers that have together received 424 indexed citations. Recurring topics across this work include Pregnancy and preeclampsia studies (5 papers), Estrogen and related hormone effects (4 papers), Maternal and fetal healthcare (3 papers), Neurological Complications and Syndromes (3 papers), Hypothalamic control of reproductive hormones (3 papers), Endometriosis Research and Treatment (3 papers), Cardiovascular Issues in Pregnancy (3 papers) and Menopause: Health Impacts and Treatments (3 papers). The work is most often cited by research in Obstetrics and Gynecology (223 citations), Reproductive Medicine (73 citations), Pediatrics, Perinatology and Child Health (166 citations), Endocrinology, Diabetes and Metabolism (116 citations) and Genetics (103 citations). Laurence Skillern has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Philip N. Baker, Alison McLeod, Gary Mires, Andrew Shennan, David Howe, Graeme L. Fraser, Steven Ramael, Samuel Lederman, Arthur Waldbaum and Nanette Santoro. Their work appears in journals such as Hypertension in Pregnancy, Menopause The Journal of The North American Menopause Society, Annals of the Rheumatic Diseases, Acta Obstetricia Et Gynecologica Scandinavica and Human Reproduction.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact